StemSight
PrivateLast Round
Seed
Feb 11, 2025
Total Funding Raised
$1.89M
Company Overview
StemSight is a biotechnology company developing off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs) to treat corneal blindness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, 3D Printing, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StemSight Comparables
Compare StemSight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellusion Inc. | 77% | |
| Alcon | 74% | |
| Chiesi Farmaceutici S.p.A. | 73% |
StemSight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 11, 2025 | ||||
| Pre Seed | Aug 31, 2021 |
Key People
Founding team and executive leadership
StemSight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Finland | Seed |
| Biothom Oy | Seed |
| European Regional Development Fund (ERDF) | Grant |
| Voima Ventures | Pre Seed, Seed |
| Avohoidon Tutkimussäätiö | Pre Seed |
| Stephen Industries Inc Oy | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 891% MoM.
- Jan 6, 2026
Monthly visitors grew 258% MoM, reaching 974.
StemSight Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about StemSight's valuation, stock price, and market status.
Is StemSight a public or private company?
StemSight is a private company.
What is the current stock price of StemSight?
StemSight is a private company with no public stock price. No recent secondary market data is available.
How much is StemSight worth (valuation)?
Valuation information for StemSight is not publicly available.
Can I buy StemSight stock?
StemSight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was StemSight's last funding round?
StemSight's most recent funding round was Seed on February 11, 2025.
Who are the main investors in StemSight?
Key investors in StemSight include Voima Ventures.
Will StemSight IPO soon?
No public IPO plans have been announced for StemSight.
How can I track StemSight secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor StemSight's secondary market activity and sign up for updates.